Biogen Idec (BIIB), Isis Pharma (ISIS) Enter Exclusive DM1 Treatment Development Collaboration
Go back to Biogen Idec (BIIB), Isis Pharma (ISIS) Enter Exclusive DM1 Treatment Development Collaboration| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 209.83 -0.82 (0.39%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $210.65 | 52 Week High | $333.65 | |||
| Open | $210.01 | 52 Week Low | $223.02 | |||
| Day High | $210.79 | P/E | 26.87 | |||
| Day Low | $208.22 | EPS | $7.81 | |||
| Volume | 554,817 | |||||
| Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) | Delayed: 57.56 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $57.56 | 52 Week High | $77.80 | |||
| Open | $3.73 | 52 Week Low | $37.38 | |||
| Day High | $57.56 | P/E | N/A | |||
| Day Low | $57.56 | EPS | $-0.35 | |||
| Volume | 15 | |||||
